鄰近類別 專利 [0/2] 期刊論文 [57/59] 類別統計 近3年內發表的文件:0(0.00%) 含全文筆數:14(93.33%) 文件下載次數統計 下載大於0次:14(100.00%) 下載大於100次:14(100.00%) 檔案下載總次數:8354(15.80%) 最後更新時間: 2024-12-01 16:12 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Targeting cathepsin S induces tumor... MPT0B098, a novel microtubule inhib... HQO-0601, an amide-containg 3, 4-di... Activation of NRF2/ABCC1 axis confe... Activation of Akt/FoxO axis confers... Blockage of Nrf2/AKR1C axis enhance... DNA repair enzyme, O6-methylguanine... Drug design for BPR0L075 as an anti... Drug design of BPR0L075 as an antic... Combined modalities of resistance i...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-15 / 15. (共1頁) 1  每頁顯示[10|25|50]項目

日期	題名	關聯
2012-11	Blockage of Nrf2/AKR1C axis enhanced therapeutic efficacy of oxaliplatin in oxaliplatin resistant gastric cancer cells	European Journal of Cancer. 2012 Nov;48(Suppl. 6):48.
2011-09	DNA repair enzyme, O6-methylguanine DNa methyltransferase, modulates therapeutic efficacy of platinum drugs with radiation and its clinical significance	European Journal of Cancer. 2011 Sep;47:S132.
2011-04	Activation of NRF2/ABCC1 axis confers resistance to topoisomerase II poisons in human oral malignancies	Cancer Research. 2011 Apr;71:Abstract number 1528.
2011-04	Activation of Akt/FoxO axis confers resistance to cisplatin in human nasopharyngeal carcinomas	Cancer Research. 2011 Apr;71:Abstract number 1701.
2011-04	MPT0B098, a novel microtubule inhibitor, displays potent anti-angiogenic activity via destabilizing hypoxia-inducible factor-1alpha mRNA	Cancer Research. 2011 Apr;71(Suppl. 8):Meeting Abstract 4461.
2011-04	Targeting cathepsin S induces tumor cell autophagy via the EGFR-ERK signaling pathway	Cancer Research. 2011 Apr;71(Suppl. 8):Meeting Abstract 2864.
2010-10	Combined modalities of resistance in a cisplatin-driven human betel-associated oral squamous cell carcinoma	Annals of Oncology. 2010 Oct;21(Suppl. 8):52.
2009-09	Synergistic augmentation of arsenic trioxide-induced cytotoxicity by BCNU through reactive oxygen species-related autophagic pathway in human solid tumors	EJC Supplements. 2009 Sep;7(3):16.
2009-05	HQO-0601, an amide-containg 3, 4-dihydroquinolinone derivative, against human hematologic malignancies through inhibition of mammalian target of repamycin signaling pathway	Cancer Research. 2009 May;69:Abstract number LB-51.
2006-11	Combined modalities of resistance in an oxaliplaitin-resistant human gastric cancer cell line with enhanced sensitivity	EJC Supplements. 2006 Nov;4(12):59.
2006-11	D-501036, a novel selenophene-base triheterocycle derivative exhibits potent in vitro and in vivo anti-tumoral activity, which involves DNA-damage and ATM activation	EJC Supplements. 2006 Nov;4(12):92.
2006-11	Tamoxifen induces degradation of the o6-methylguanine DNA methyltransferase protein via the ubiquitin-dependent proteosome pathway in human cancer cells	EJC Supplements. 2006 Nov;4(12):155.
2006-02	DNA repair enzyme, O-6-methylguanine DNA methyltransferase, modulates cytotoxicity of camptothecin-derived topoisomerase I inhibitors	Journal of Pharmacology and Experimental Therapeutics. 2006 Feb;316(2):946-954.
2004-09	Drug design of BPR0L075 as an anticancer agent	World Conference on Magic Bullets - Celebrating Paul Ehrlich's 150th Birthday. 2004 Sep 9-11:Abstract # 203.
2004-07	Drug design for BPR0L075 as an anticancer agent	Medicine in the 21st Century Tri-Conference & Bio-Forum 2004 Shanghai International Convention Center. 2004 Jul.

顯示項目1-15 / 15. (共1頁) 1  每頁顯示[10|25|50]項目